Aspreva Pharmaceuticals Corporation

Aspreva is an emerging pharmaceutical company focused on identifying, developing and, upon regulatory approval, commercializing new indications for approved drugs and late stage drug candidates for patients living with less common diseases. Aspreva's "Indication Partnering" strategy allows its partners to maintain core brand focus while extending the benefits of their medicines to a broader patient population. Aspreva is listed on the NASDAQ National Market under the trading symbol "ASPV" and on the Toronto Stock Exchange under the trading symbol "ASV". To view the Consolidated Statements, please click on the link below. ( www.aspreva.com )